Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats

OBJECTIVE: Chronic kidney disease (CKD), including nephrotic syndrome, is a major cause of cardiovascular morbidity and mortality. The literature indicates that CKD is associated with profound lipid disorders largely due to the dysregulation of lipoprotein metabolism which further aggravates the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghelani, Hardik, Razmovski-Naumovski, Valentina, Inampudi, Vamsi, Chang, Dennis, Nammi, Srinivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885231/
https://www.ncbi.nlm.nih.gov/pubmed/31828139
http://dx.doi.org/10.1155/2019/8714363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885231/
https://www.ncbi.nlm.nih.gov/pubmed/31828139
http://dx.doi.org/10.1155/2019/8714363

Ejemplares similares